October Effect LTD Cor Medix Inc. Transaction History
October Effect LTD
- $90.8 Billion
- Q4 2025
A detailed history of October Effect LTD transactions in Cor Medix Inc. stock. As of the latest transaction made, October Effect LTD holds 306,444 shares of CRMD stock, worth $3.48 Million. This represents 3.93% of its overall portfolio holdings.
Number of Shares
306,444
Previous 420,551
27.13%
Holding current value
$3.48 Million
Previous $4.89 Billion
27.13%
% of portfolio
3.93%
Previous 5.39%
Shares
3 transactions
Others Institutions Holding CRMD
# of Institutions
207Shares Held
41.5MCall Options Held
1.33MPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA3.98MShares$45.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X03.47MShares$39.4 Million0.05% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.32MShares$37.7 Million0.74% of portfolio
-
State Street Corp Boston, MA1.84MShares$20.8 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $467M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...